Sökning: WFRF:(Arvidsson S) > (2010-2014) > Pentacycloundecane-...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 03631naa a2200541 4500 | |
001 | oai:DiVA.org:uu-152860 | |
003 | SwePub | |
008 | 110502s2011 | |||||||||||000 ||eng| | |
009 | oai:DiVA.org:umu-80019 | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-1528602 URI |
024 | 7 | a https://doi.org/10.1016/j.bmcl.2011.02.1052 DOI |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-800192 URI |
040 | a (SwePub)uud (SwePub)umu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Makatini, Maya M.4 aut |
245 | 1 0 | a Pentacycloundecane-based inhibitors of wild-type C-South African HIV-protease |
264 | 1 | b Elsevier BV,c 2011 |
338 | a print2 rdacarrier | |
520 | a In this study, we present the first account of pentacycloundecane (PCU) peptide based HIV-protease inhibitors. The inhibitor exhibiting the highest activity made use of a natural HIV-protease substrate peptide sequence, that is, attached to the cage (PCU-EAIS). This compound showed nanomolar IC50 activity against the resistance-prone wild type C-South African HIV-protease (C-SA) catalytic site via a norstatine type functional group of the PCU hydroxy lactam. NMR was employed to determine a logical correlation between the inhibitory concentration (IC50) results and the 3D structure of the corresponding inhibitors in solution. NMR investigations indicated that the activity is related to the chirality of the PCU moiety and its ability to induce conformations of the coupled peptide side chain. The results from docking experiments coincided with the experimental observed activities. These findings open up useful applications for this family of cage peptide inhibitors, considering the vast number of alternative disease related proteases that exist. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Medicinska och farmaceutiska grundvetenskaperx Farmaceutiska vetenskaper0 (SwePub)301012 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Basic Medicinex Pharmaceutical Sciences0 (SwePub)301012 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Medicinska och farmaceutiska grundvetenskaperx Läkemedelskemi0 (SwePub)301032 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Basic Medicinex Medicinal Chemistry0 (SwePub)301032 hsv//eng |
653 | a Pentacycloundecane peptides | |
653 | a HIV-protease inhibitor | |
653 | a EASY-ROESY | |
653 | a Inhibitory concentration (IC50) | |
653 | a Molecular docking | |
653 | a PHARMACY | |
653 | a FARMACI | |
700 | 1 | a Petzold, Katjau School of Chemistry, University of KwaZulu-Natal, Durban 4001, South Africa4 aut0 (Swepub:umu)kape0005 |
700 | 1 | a Sriharsha, Shimoga N.4 aut |
700 | 1 | a Soliman, Mahmoud E. S.4 aut |
700 | 1 | a Honarparvar, Bahareh4 aut |
700 | 1 | a Arvidsson, Per I.u Uppsala universitet,Avdelningen för organisk farmaceutisk kemi4 aut0 (Swepub:uu)pearv049 |
700 | 1 | a Sayed, Yasien4 aut |
700 | 1 | a Govender, Patrick4 aut |
700 | 1 | a Maguire, Glenn E. M.4 aut |
700 | 1 | a Kruger, Hendrik G.4 aut |
700 | 1 | a Govender, Thavendran4 aut |
710 | 2 | a School of Chemistry, University of KwaZulu-Natal, Durban 4001, South Africab Avdelningen för organisk farmaceutisk kemi4 org |
773 | 0 | t Bioorganic & Medicinal Chemistry Lettersd : Elsevier BVg 21:8, s. 2274-2277q 21:8<2274-2277x 0960-894Xx 1464-3405 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-152860 |
856 | 4 8 | u https://doi.org/10.1016/j.bmcl.2011.02.105 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-80019 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy